查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840707

顱內動脈瘤市場按治療類型、動脈瘤位置、患者年齡層和最終用戶分類 - 全球預測，2025-2032 年

Intracranial Aneurysm Market by Treatment Type, Aneurysm Location, Patient Age Group, End Users - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，顱內動脈瘤市場規模將達到 83.8 億美元，複合年成長率為 22.93%。

關鍵市場統計數據
基準年 2024 16億美元
預計年份：2025年 19.7億美元
預測年份 2032 83.8億美元
複合年成長率 (%) 22.93%

本書全面介紹了顱內動脈瘤治療中涉及的臨床複雜性、診斷進展和多學科治療路徑，這些因素共同重塑了顱內動脈瘤的治療模式。

顱內動脈瘤的治療涉及神經外科、血管內治療、先進影像技術以及不斷發展的圍手術手術全期護理模式的複雜交叉領域。過去十年間，臨床醫生和器械研發人員在保留外科手術技術以應對解剖結構複雜的病變的同時，也逐漸轉向微創治療方法。這種融合得益於器械設計和影像解析度的不斷改進，從而提高了手術精度和患者選擇標準。

當代臨床路徑強調早期發現、風險分層和多學科治療計劃，整合重症加護、介入性神經放射學和神經外科。高解析度血管影像和動態壓力電腦評估等診斷技術的進步，提高了臨床醫師對病變形態和破裂風險的判斷能力。同時，手術流程的改進和圍手術全期通訊協定的完善縮短了住院時間和降低了手術全期併發症發生率，從而促進了門診和混合治療模式的廣泛應用。

儘管技術不斷進步，但仍存在諸多障礙。解剖結構的複雜性、患者的合併症以及醫療機構專業水平的差異仍然是影響治療決策的關鍵因素。保險報銷動態、供應鏈壓力和監管路徑也會影響新型醫療器材的推廣應用。因此，各相關人員必須權衡臨床證據、運作能力和採購實際情況，以最佳化顱內動脈瘤患者的診療服務。

設備、影像和手術策略的快速進步正在推動精準醫療和顱內動脈瘤治療系統層級變革的新時代。

顱內動脈瘤治療領域正經歷變革性的轉變，涵蓋器材創新、診斷技術和手術策略等多個面向。器械創新持續朝著低輪廓、軟性結構的方向發展，這些結構能夠適應迂曲的神經血管解剖結構，同時提高輸送性和促進血管癒合。血流調節和彈簧圈技術的進步改變了治療流程，使得以往被認為不適合開放性手術的高風險解剖結構也能得到治療。

隨著影像技術的進步和計算工具的整合，診斷技術也得到了顯著提升，能夠量化動脈瘤壁應力和血流模式。這些改進的診斷方法實現了更精細的風險分層，並指導了介入治療的時機和方法。在手術操作方面，當解剖特徵和先前介入經驗決定了每個病例的個人化治療方法時，結合血管內和顯微外科技術的混合方法正被擴大採用。

同時，諸如門診服務的擴展和以價值為導向的醫療模式等系統層面的變革正在重塑醫療服務的提供方式和地點。醫療器材製造商、卓越臨床中心和數位醫療創新者之間的夥伴關係正在加速培訓、遠端原型設計和結果監測方面的迭代改進。這些累積性的轉變正在重新定義標準治療提案，並為那些能夠將臨床證據與營運準備和採購靈活性相結合的相關人員創造新的機會。

評估2025年美國關稅調整如何重塑動脈瘤治療領域的供應鏈、採購慣例與臨床服務路徑

2025年關稅政策的實施為顱內動脈瘤治療的供應鏈帶來了複雜的貿易政策考量。依賴跨境採購植入、特殊金屬和精密零件的製造商正面臨原物料成本上漲和前置作業時間延長的雙重挑戰。為此，許多供應商正在重新評估其採購佈局，優先考慮供應商多元化以及降低對單一供應商依賴性的協議。

醫院採購團隊和臨床服務提供者正感受到部分設備採購價格上漲以及庫存管理日益嚴格帶來的衝擊。這些壓力促使他們與供應商簽訂更長期的契約，並更傾向於批量採購以穩定單位成本。此外，與監管合規和海關相關的行政負擔也導致補貨週期延長，促使醫療機構持有更大的安全庫存或評估替代醫療設備方案，以避免手術中斷。

從戰略層面來看，關稅環境正在加速關於近岸外包和區域製造夥伴關係的討論，這些合作可以減輕關稅波動的影響。醫療器材開發商和經銷商正在探索本地組裝和零件採購，以保持競爭力。同時，臨床醫生和醫院領導者正在重新評估其採購框架，以平衡成本控制和臨床質量，優先考慮與那些展現可靠性、本地支援和清晰的上市後監測能力的供應商合作。這些動態正在重塑整個生態系統的商業策略和營運計劃。

基於細分市場的洞察分析解釋了治療方式、動脈瘤位置、患者人口統計特徵和臨床環境如何影響臨床路徑和應用動態。

分段動態揭示了不同治療方式、解剖位置、患者群體和治療環境的差異化採用模式和臨床考慮因素：血管內卷取仍然是治療方法具有血管內通路囊狀病變的主要方法；血流導向擴大了寬頸部動脈瘤和動脈瘤樣動脈瘤的選擇範圍，這些動脈瘤需要進行重組；而對於非常複雜的血管分叉結構或需要即時機械排除的病變。

動脈瘤的位置會進一步影響臨床決策。前交通動脈、基底動脈、大腦中動脈和後交通動脈的病變會帶來獨特的技術挑戰和破裂風險，進而影響治療方法、輔助器具的使用以及預期的圍手術全期過程。成年患者通常合併多種併發症，這會影響抗血小板治療方案和裝置的選擇；老年患者需要仔細權衡手術獲益與衰弱相關風險；而兒童患者則需要使用特殊的裝置和終身監測策略，以考慮生長發育和長期耐久性。

最終使用者塑造醫療服務模式和資源分配。對於復健軌跡可預測的擇期血管內治療病例，門診手術中心的重要性日益凸顯；診斷中心在早期檢測和非侵入性監測途徑中發揮關鍵作用；而醫院憑藉其綜合重症監護和神經外科能力，仍然是複雜介入治療和急性破裂處理的主要場所。總而言之，這些細分決定了整個醫療服務過程中的臨床路徑、採購重點和投資決策。

美洲、歐洲、中東、非洲和亞太地區顱內動脈瘤治療的臨床應用、基礎設施投資和就醫途徑的區域觀點

臨床實務、法律規範和醫療基礎設施的區域差異導致各大全部區域顱內動脈瘤治療方法的差異化。在美洲，集中化的專科護理、整合的診療路徑以及日益重視手術療效的報銷模式，促進了先進血管內手術和輔助技術的快速應用。該地區的臨床網路和轉診模式通常促使高複雜度病例集中到三級醫療中心，同時允許對部分病例進行門診手術。

歐洲、中東和非洲地區的情況各不相同：中東和非洲正致力於基礎設施建設、培養本地專家並改善診斷影像服務的可近性。監管協調工作和區域採購聯盟將影響設備上市時間和定價，製造商需要據此調整打入市場策略。

亞太地區正經歷製造業產能的快速擴張、對三級神經血管中心的投資增加，以及部分國家對本土醫療器材研發的重視。某些人群中未確診腦血管疾病的高發生率促使人們更加關注篩檢工作和診斷中心的擴張。在所有地區，跨國合作、臨床訓練交流和遠距指導正日益成為轉移診療流程和技術的重要機制，從而減少治療結果的差異，並加速實證醫學方法的推廣應用。

公司層級的分析重點闡述了現有製造商、專注的創新者以及服務聯盟如何重塑設備組合和臨床應用軌跡。

公司層面的動態反映了成熟製造商、靈活敏捷的專業公司以及推動創新設備平台和數位輔助設備發展的新興參與企業的融合。成熟的醫療設備製造商繼續利用其全球分銷管道、監管經驗和豐富的臨床證據，支持成熟技術的廣泛臨床應用。同時，專業公司和新興企業則專注於差異化的技術優勢——例如，新型血流調節結構、促進內皮化的生物活性塗層以及優先考慮在複雜解剖結構中導航的新一代遞送系統。

設備開發商與數位醫療服務提供者之間的合作日益普遍，夥伴關係在於高階影像分析、運算流體建模和上市後結果追蹤。這些合作有助於展示設備性能對比，支持臨床醫生培訓，並產生真實世界證據，從而加速醫療機構的採納。此外，隨著醫院和門診中心尋求縮短複雜干預措施的學習曲線，提供端到端培訓、遠端原型設計和設備支援的服務供應商也越來越受歡迎。

從競爭格局來看，成功的公司將技術差異化與強大的臨床數據、積極的監管應對措施以及本地支持能力相結合。那些投資於臨床醫生教育、實證醫學研究和供應鏈韌性的公司，更有能力應對採購審查，並在高流量中心和新興治療領域中保持市場佔有率。

為醫療器材開發商、醫療服務提供者和支付方提供切實可行的策略建議，以加速創新技術的應用、增強韌性並改善以患者為中心的動脈瘤治療。

產業領導者應優先採取一系列策略行動，在應對營運和政策限制的同時，充分利用臨床創新。首先，將產品開發與經臨床醫生驗證的用例和真實世界證據項目結合，可以減少推廣阻力，並向採購委員會展現令人信服的價值提案。與大型臨床中心密切合作，進行檢驗主導的研究、註冊登記和培訓項目，可以建立持久的信譽，並加速最佳實踐的傳播。

其次，增強供應鏈韌性至關重要。領導者應實現採購管道多元化，評估本地組裝和近岸外包的機會，並建立靈活的合約安排，包括緊急庫存和透明的前置作業時間承諾。這些措施將降低關稅主導的成本衝擊風險，並增強醫療機構維持正常運作的能力。

第三，投資於能夠縮短操作流程學習曲線的培訓和服務模式，將有助於在醫院和門診機構中廣泛應用。遠距指導、模組化培訓課程和以結果主導的支援模式可以增強臨床醫生的信心並減少操作差異。第四，積極與支付方和醫療系統合作，基於臨床結果和以患者為中心的指標闡明成本效益，可以使創新應用與報銷途徑保持一致。最後，為了展現長期價值並支持持續改進，領導者應推行可互通的數位化策略，整合影像分析、結果登記和病患報告結果。

一套透明的調查方法，描述了用於檢驗研究結果和支持策略建議的綜合臨床、商業和供應鏈分析。

本調查方法整合了臨床文獻回顧、專家訪談、器械標籤和監管文件以及供應鏈分析，以整體情況組裝動脈瘤治療的動態。關鍵的定性資料包括對介入性神經放射科醫生、神經外科醫生、採購負責人和器械設計工程師的結構化訪談，旨在揭示實際應用中的限制因素、技術性能考量以及推動技術應用的因素。這些觀點與同行評審的臨床研究、操作指南和官方監管文件進行交叉比對，以確保技術準確性和臨床相關性。

我們的供應鏈和政策分析依賴貿易數據、採購案例研究和公開的關稅表，以評估近期政策變化如何影響設備可用性和前置作業時間。在適當情況下，我們將基於情境的影響評估納入我們的方法論，以探索應對供應中斷的潛在營運措施，而不做出確定性預測。資料檢驗步驟包括交叉核對專家回饋和文獻證據，以及透過迭代審查來消除分歧並確保我們見解的可靠性。

最終形成的框架強調臨床、商業性和營運視角，以支持針對不同相關人員的可操作建議，這些利益相關者包括設備創新者和醫院採購團隊、臨床教育者和政策顧問。

簡明扼要的結論整合了臨床進展、機構挑戰和策略重點，旨在為致力於改善動脈瘤治療效果和患者可及性的相關人員提供參考。

本分析整合了臨床創新、供應鏈演變和策略影響，全面展現了目前顱內動脈瘤治療的動態。器械技術和影像技術的進步極大地拓展了治療選擇，而採購壓力和貿易政策變化等系統層面的因素則引入了新的營運考量，影響著治療方案的採納和普及。這些趨勢的交匯凸顯了將臨床證據的產生與穩健的商業策略和針對性的臨床醫生支持相結合的重要性。

跨臨床、監管和供應鏈領域協調一致的相關人員最能有效減少干擾，同時加速有益技術的長期應用。透過專注於結果、投資臨床醫生培訓以及實施符合當地實際情況的供應鏈策略，醫療機構可以保持診療流程的連續性並最佳化患者療效。總之，推動醫療發展需要製定一項綜合計劃，在技術創新應用和務實營運管理之間取得平衡，以確保臨床進步能夠轉化為患者照護的實際改善。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 安全性的提升促使血流導向裝置在複雜顱內動脈瘤的治療上得到更廣泛的應用。
  • 整合人工智慧驅動的影像平台以提高臨床環境中動脈瘤的早期檢測率
  • 開發可生物吸收的聚合物塗層神經血管支架，以減少發炎並促進血管癒合
  • 血管內微導管技術的進步使得進入遠端和迂曲的腦血管成為可能。
  • 越來越多的臨床證據支持使用囊內止血植入治療寬頸動脈瘤。
  • 針對特定患者的計算流體力學模型在預測動脈瘤破裂風險和治療反應方面的應用日益廣泛。
  • 遠距遠端醫療的普及使得中風和動脈瘤的追蹤通訊協定得以實施，並改善了術後病患監測。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依治療類型分類的顱內動脈瘤市場

  • 血管內彈簧圈栓塞術
  • 流量轉換
  • 手術夾

9. 按動脈瘤位置分類的顱內動脈瘤市場

  • 前交通動脈
  • 基底動脈
  • 大腦中動脈
  • 後交通動脈

第10章 依病患年齡層別分類的顱內動脈瘤市場

  • 成人版
  • 老年人
  • 孩子們

第11章 以最終用戶分類的顱內動脈瘤市場

  • 門診手術中心
  • 診斷中心
  • 醫院

12. 各地區顱內動脈瘤市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 顱內動脈瘤市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國顱內動脈瘤市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson
    • Terumo Corporation
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Abbott Laboratories
Product Code: MRR-A339DAEF9EC7

The Intracranial Aneurysm Market is projected to grow by USD 8.38 billion at a CAGR of 22.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.60 billion
Estimated Year [2025] USD 1.97 billion
Forecast Year [2032] USD 8.38 billion
CAGR (%) 22.93%

A comprehensive introduction framing clinical complexity, diagnostic advances, and multidisciplinary care pathways reshaping intracranial aneurysm management

Intracranial aneurysm management occupies a complex intersection of neurosurgery, endovascular therapy, advanced imaging, and evolving perioperative care models. Over the past decade clinicians and device developers have shifted toward minimally invasive approaches while preserving surgical techniques for anatomically challenging lesions. This convergence has been driven by continuous improvements in device design and imaging resolution, which together improve procedural precision and patient selection.

Contemporary clinical pathways emphasize early detection, risk stratification, and interdisciplinary care planning that integrates neurocritical care, interventional neuroradiology, and neurosurgery. Diagnostic advances such as high-resolution vascular imaging and computational assessments of hemodynamic stress have enhanced clinicians' ability to characterize lesion morphology and rupture risk. Meanwhile, procedural refinements and enhanced perioperative protocols have reduced length of stay and perioperative morbidity, supporting broader adoption of ambulatory and hybrid care models.

Despite technological progress, barriers remain. Anatomical complexity, patient comorbidities, and variability of institutional expertise continue to shape treatment decisions. Reimbursement dynamics, supply chain pressures, and regulatory pathways also influence adoption timelines for novel devices. Consequently, strategic stakeholders must reconcile clinical evidence, operational capacity, and procurement realities to optimize care delivery for patients with intracranial aneurysms.

Rapid advancements in devices, imaging, and procedural strategies are catalyzing a new era of precision care and system-level change for intracranial aneurysm treatment

The landscape of intracranial aneurysm care is experiencing transformative shifts that span device innovation, diagnostic sophistication, and procedural strategy. Device innovation continues to favor low-profile, flexible constructs that accommodate tortuous neurovascular anatomy while improving deliverability and vessel healing. Flow modulation technologies and refinements in coil technology have altered therapeutic algorithms, enabling clinicians to treat anatomies that were once considered high risk for open surgery.

Diagnostics have kept pace through enhanced imaging modalities and the integration of computational tools that quantify aneurysm wall stress and flow patterns. These diagnostic improvements enable more granular risk stratification, guiding the timing and modality of intervention. Procedurally, there is growing adoption of hybrid approaches that combine endovascular and microsurgical techniques when anatomy or prior interventions demand a tailored solution.

Concurrently, systems-level changes-such as the expansion of ambulatory procedural settings and greater emphasis on value-based care-are reshaping where and how treatments are delivered. Partnerships between device manufacturers, clinical centers of excellence, and digital health innovators are accelerating iterative improvements in training, remote proctoring, and outcome monitoring. These cumulative shifts are redefining standard-of-care propositions and creating new opportunities for stakeholders who can align clinical evidence with operational readiness and procurement agility.

Assessment of how the 2025 United States tariff adjustments have reshaped supply chains, procurement practices, and clinical delivery pathways in aneurysm care

The tariff measures implemented in 2025 have introduced a complex overlay of trade policy considerations into the supply chains that support intracranial aneurysm care. Manufacturers that rely on cross-border sourcing for implants, specialized metals, and precision components have faced elevated input costs and extended lead times. In response, many suppliers have reevaluated sourcing footprints, prioritizing supplier diversification and contracts that mitigate single-source dependencies.

Hospital procurement teams and clinical service providers have felt the reverberations through higher acquisition prices for select devices and the need for more rigorous inventory management. These pressures have prompted a shift toward longer-term supplier agreements and increased interest in bundled purchasing arrangements to stabilize unit costs. Regulatory compliance and customs-related administrative burdens have also contributed to slower replenishment cycles, encouraging providers to hold larger safety stocks or to qualify alternative device options to avoid procedural interruptions.

At the strategic level, the tariff environment has accelerated conversations about nearshoring and regional manufacturing partnerships that can reduce exposure to tariff volatility. Device developers and distributors are exploring localized assembly and component sourcing to preserve competitiveness. In parallel, clinicians and hospital leaders are reassessing procurement frameworks to balance cost containment with clinical quality, emphasizing vendor partnerships that demonstrate reliability, local support, and clear post-market surveillance capabilities. These dynamics are reshaping commercial strategies and operational planning across the ecosystem.

Segment-driven insights explaining how treatment modalities, aneurysm locations, patient demographics, and clinical settings influence clinical pathways and adoption dynamics

Segment-level dynamics reveal differentiated adoption patterns and clinical considerations across treatment modalities, anatomical locations, patient demographics, and care settings. When analyzed by treatment type-Endovascular Coiling, Flow Diversion, and Surgical Clipping-each modality presents distinct strengths: coiling remains a mainstay for saccular lesions amenable to endovascular access; flow diversion has expanded options for wide-neck and fusiform aneurysms where vessel reconstruction is desirable; and surgical clipping retains importance for complex bifurcation anatomy and ruptured lesions where immediate mechanical exclusion is required.

Aneurysm location further nuances clinical decision making. Lesions arising in the anterior communicating artery, basilar artery, middle cerebral artery, and posterior communicating artery exhibit unique technical challenges and rupture risk profiles, influencing modality selection, adjunct device use, and anticipated perioperative courses. Patient age group segmentation also affects therapeutic strategy: adult patients commonly present with a wider array of comorbidities that influence antiplatelet planning and device choice, geriatric patients require careful balance between procedural benefit and frailty-related risk, and pediatric cases demand specialized devices and lifelong surveillance strategies that account for growth and long-term durability.

End users shape delivery models and resource allocation. Ambulatory Surgery Centers are increasingly relevant for select elective endovascular cases with predictable recovery trajectories, Diagnostic Centers play a pivotal role in early detection and noninvasive surveillance pathways, and Hospitals continue to be the primary site for complex interventions and acute rupture management due to their integrated critical care and neurosurgical capabilities. Taken together, these segmentation lenses inform clinical pathways, procurement priorities, and investment decisions across the continuum of care.

Regional perspectives on clinical adoption, infrastructure investment, and access pathways shaping intracranial aneurysm care across the Americas, EMEA, and Asia-Pacific

Regional variations in clinical practice, regulatory frameworks, and healthcare infrastructure drive differentiated approaches to intracranial aneurysm care across the major geographies. In the Americas, a concentration of specialized centers, integrated care pathways, and reimbursement models that increasingly reward procedural efficacy support rapid adoption of advanced endovascular techniques and ancillary technologies. Clinical networks and referral patterns in this region often facilitate centralization of high-complexity cases in tertiary centers while enabling ambulatory procedural growth for suitable elective cases.

In Europe, Middle East & Africa, heterogeneity is pronounced: Western European systems frequently combine strong clinical trial ecosystems with well-established neurointerventional programs, whereas segments of the Middle East and Africa are focused on building infrastructure, training local specialists, and improving access to diagnostic imaging. Regulatory harmonization efforts and regional procurement consortia influence device introduction timelines and pricing dynamics, prompting manufacturers to tailor market entry strategies accordingly.

The Asia-Pacific region demonstrates rapid capacity expansion, investment in tertiary neurovascular centers, and a strong emphasis on domestic device development in some countries. A high burden of undiagnosed cerebrovascular disease in certain populations has heightened focus on screening initiatives and diagnostic center expansion. Across all regions, cross-border collaborations, clinical training exchanges, and remote proctoring are increasingly important mechanisms for transferring technique and technology, thereby reducing variability in outcomes and accelerating uptake of evidence-based approaches.

Company-level analysis highlighting how established manufacturers, focused innovators, and service partnerships are reshaping device portfolios and clinical adoption trajectories

Company-level dynamics reflect a blend of entrenched manufacturers, agile specialist firms, and new entrants pushing on innovative device platforms and digital adjuncts. Established medical device companies continue to leverage global distribution channels, regulatory experience, and extensive clinical evidence to support broad clinical adoption of staple technologies. At the same time, specialized firms and startups concentrate on differentiated technical advantages-such as novel flow modulation architectures, bioactive coatings that promote endothelialization, and next-generation delivery systems that prioritize navigability in tortuous anatomy.

Collaborations between device developers and digital health providers are becoming more prevalent, with partnerships focused on advanced imaging analytics, computational fluid modeling, and post-market outcome tracking. These arrangements help demonstrate comparative performance, support clinician training, and generate real-world evidence that can accelerate institutional adoption. In addition, service providers offering end-to-end training, remote proctoring, and device support are gaining prominence as hospitals and ambulatory centers seek to reduce learning curve barriers for complex interventions.

Across the competitive landscape, successful firms combine technical differentiation with robust clinical data, proactive regulatory engagement, and local support capabilities. Companies that invest in clinician education, evidence generation, and supply chain resilience are better positioned to navigate procurement scrutiny and to sustain uptake within high-volume centers as well as emerging treatment sites.

Practical strategic recommendations for device developers, providers, and payers to accelerate innovation adoption, enhance resilience, and improve patient-centered aneurysm care

Industry leaders should prioritize a set of strategic actions to capitalize on clinical innovation while addressing operational and policy constraints. First, aligning product development with clinician-validated use cases and real-world evidence programs will reduce adoption friction and generate compelling value propositions for procurement committees. Close collaboration with high-volume clinical centers for investigator-initiated studies, registries, and training programs can create durable credibility and accelerate dissemination of best practices.

Second, strengthening supply chain resilience is essential. Leaders should diversify sourcing, evaluate regional assembly or nearshoring opportunities, and establish flexible contracting arrangements that include contingency inventory and transparent lead-time commitments. These steps reduce exposure to tariff-driven cost shocks and enhance the ability to support procedural continuity at provider sites.

Third, investing in training and service models that lower procedural learning curves will facilitate broader adoption across hospitals and ambulatory settings. Remote proctoring, modular training curricula, and outcome-driven support models can increase clinician confidence and reduce procedural variability. Fourth, engaging proactively with payers and health systems to articulate cost-effectiveness narratives grounded in clinical outcomes and patient-centered metrics will help align reimbursement pathways with innovation adoption. Finally, leaders should pursue interoperable digital strategies that integrate imaging analytics, outcome registries, and patient-reported outcomes to demonstrate long-term value and support continuous improvement.

Transparent research methodology describing integrated clinical, commercial, and supply chain analyses used to validate insights and support strategic recommendations

The research synthesis draws on a multi-modal methodology that integrates clinical literature review, expert interviews, device labeling and regulatory documentation, and supply chain analyses to assemble a holistic view of intracranial aneurysm care dynamics. Primary qualitative inputs include structured interviews with interventional neuroradiologists, neurosurgeons, procurement leaders, and device design engineers to surface real-world constraints, technology performance considerations, and adoption drivers. These perspectives were triangulated with peer-reviewed clinical studies, procedural guidelines, and public regulatory filings to ensure technical accuracy and clinical relevance.

Supply chain and policy analyses relied on trade data, procurement case studies, and publicly available tariff schedules to assess how recent policy shifts influence device availability and lead times. Where appropriate, the methodology incorporated scenario-based impact assessments to explore potential operational responses to supply disruptions, without producing deterministic forecasts. Data validation steps included cross-referencing expert feedback with documentary evidence, and iterative review cycles to reconcile divergent views and ensure robustness of insights.

The result is a framework that emphasizes clinical, commercial, and operational lenses and that supports actionable recommendations tailored to diverse stakeholders, from device innovators and hospital procurement teams to clinician educators and policy advisors.

Concise conclusion that integrates clinical progress, systemic challenges, and strategic priorities for stakeholders committed to improving aneurysm outcomes and access

This analysis synthesizes clinical innovation, supply chain evolution, and strategic implications to present a cohesive view of current intracranial aneurysm care dynamics. Advances in device technology and imaging have materially expanded therapeutic options, while system-level forces-such as procurement pressures and trade policy shifts-have introduced new operational considerations that affect adoption and access. The intersection of these trends underscores the importance of aligning clinical evidence generation with resilient commercial strategies and targeted clinician support.

Stakeholders who coordinate across clinical, regulatory, and supply chain domains will be best positioned to accelerate durable adoption of beneficial technologies while mitigating disruption. Emphasizing outcomes, investing in clinician training, and pursuing regionally informed supply chain strategies will help institutions maintain procedural continuity and optimize patient outcomes. In sum, the path forward requires integrated planning that balances innovation uptake with pragmatic operational controls, thereby ensuring that clinical advances translate into tangible improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of flow diverter devices for complex intracranial aneurysm treatment due to improved safety profiles
  • 5.2. Integration of artificial intelligence driven imaging platforms to improve early aneurysm detection rates in clinical practice
  • 5.3. Development of bioresorbable polymer coated neurovascular stents for reduced inflammation and vessel healing
  • 5.4. Advances in endovascular microcatheter technology enabling access to distal and tortuous cerebral vessels
  • 5.5. Growing clinical evidence supporting intrasaccular flow disruption implants for wide neck aneurysm management
  • 5.6. Emergence of patient specific computational fluid dynamics modeling to predict aneurysm rupture risk and treatment response
  • 5.7. Expansion of telemedicine enabled stroke and aneurysm follow up protocols to improve post procedural patient monitoring

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intracranial Aneurysm Market, by Treatment Type

  • 8.1. Endovascular Coiling
  • 8.2. Flow Diversion
  • 8.3. Surgical Clipping

9. Intracranial Aneurysm Market, by Aneurysm Location

  • 9.1. Anterior Communicating Artery
  • 9.2. Basilar Artery
  • 9.3. Middle Cerebral Artery
  • 9.4. Posterior Communicating Artery

10. Intracranial Aneurysm Market, by Patient Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Intracranial Aneurysm Market, by End Users

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals

12. Intracranial Aneurysm Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intracranial Aneurysm Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intracranial Aneurysm Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Stryker Corporation
    • 15.3.3. Johnson & Johnson
    • 15.3.4. Terumo Corporation
    • 15.3.5. Boston Scientific Corporation
    • 15.3.6. Penumbra, Inc.
    • 15.3.7. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY BASILAR ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY MIDDLE CEREBRAL ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY POSTERIOR COMMUNICATING ARTERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 108. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 118. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 148. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 152. MIDDLE EAST INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 158. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 159. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 162. AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 180. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 181. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 184. ASEAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 185. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 190. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 191. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 194. GCC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPEAN UNION INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 205. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 210. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 211. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 214. BRICS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 215. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 220. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 221. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 224. G7 INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 225. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 230. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 231. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 234. NATO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 241. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 245. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 248. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 249. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 252. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 253. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 257. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 261. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 265. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 272. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 277. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 280. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 281. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 284. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 285. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 289. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 293. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 296. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 297. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 301. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 305. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 309. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 313. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 315. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 317. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 320. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 321. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 322. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 323. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 324. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 325. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2018-2024 (USD MILLION)
  • TABLE 328. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY ANEURYSM LOCATION, 2025-2032 (USD MILLION)
  • TABLE 329. IND